{
    "title": "Life-extending prostate drug is ruled out for NHS use as officials deem it's not worth the money",
    "url": "https://www.dailymail.co.uk/health/article-10369927/Life-extending-prostate-drug-ruled-NHS-use-officials-deem-not-worth-money.html",
    "date": "2022-01-05",
    "keywords": [
        "cancer",
        "olaparib",
        "drug",
        "treatment",
        "prostate",
        "use",
        "evidence",
        "year",
        "trial",
        "uk",
        "cabazitaxel",
        "nhs",
        "precision",
        "disease",
        "scotland",
        "england",
        "care",
        "nice",
        "charity",
        "medicine",
        "share",
        "retreatment",
        "abiraterone",
        "makeup",
        "cancerit",
        "institute",
        "health",
        "excellence",
        "price",
        "pack",
        "course",
        "gland",
        "bladder",
        "ten",
        "decade",
        "stock",
        "imagethe",
        "size",
        "hobbs",
        "professor",
        "icr",
        "leader",
        "profound",
        "life",
        "chemotherapyi",
        "disappointing",
        "decision",
        "example",
        "postcode",
        "prescribing",
        "timebomb",
        "survivor",
        "covid",
        "article",
        "hormone",
        "therapy",
        "radium223",
        "dichloridenice",
        "time",
        "enzalutamide",
        "nhsnice",
        "comparison",
        "saidprostate",
        "consortium",
        "decisionby",
        "account",
        "uncertainty",
        "risk"
    ],
    "category": [
        "health"
    ]
}